Skip to content

Fulgent Genetics, Inc. FLGT Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$75.01M-79.1%-$61.63M-40.6%-$44.17M+74.3%-$52.04M+69.5%-$41.87M+75.8%
$24.2M+0.1%$24.12M-3.2%$24.2M-4.2%$24.09M-6.5%$24.18M-6.7%
$38.92M-10.6%$39.58M-11.0%$40.71M-10.5%$41.92M-7.8%$43.51M-1.5%
-$25.09M-168%$9.36M-77.8%
$23.06M-43.7%$22.57M-44.0%$21.37M-46.1%$34.86M+39.3%$40.98M+69.1%
$0-100%
$94.58M$111.37M$72.76M
-$48.45M-267%-$14.79M-205%-$14.58M+52.1%-$14.7M+57.2%-$13.21M+73.3%
-$43.88M-$4.95M$59.6M$22.9M
-$118.23M-$129.27M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Fulgent Genetics, Inc. generate?
Fulgent Genetics, Inc. (FLGT) generated -$105.6M in operating cash flow over the trailing twelve months.
What is Fulgent Genetics, Inc.'s free cash flow?
After $23.1M of capital expenditures, Fulgent Genetics, Inc.'s free cash flow was -$118.2M over the trailing twelve months, down 138.2% year over year.
Where does Fulgent Genetics, Inc.'s cash flow data come from?
Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.